Philogen
€22.25Change from previous close: −0.22%Absolute change: −€0.05
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- €895.26M
- Enterprise value
- €571.84M
- P/E (trailing 12 months)
- 3.99
- Forward P/E
- -89.2
- Price/book
- 2.40
- Price/sales
- 2.84
- EV/EBITDA
- 2.26
- EV/revenue
- 1.81
Profitability and growth
- Gross margin
- 87.2%
- Operating margin
- -578.8%
- Net margin
- 71.4%
- ROE
- 98.4%
- ROA
- 56.2%
- Revenue growth (year over year)
- -52.3%
Financial health
- Total cash
- €337.14M
- Total debt
- €11.44M
- Debt/equity
- 0.03
- Current ratio
- 6.99
- Quick ratio
- 6.92
Dividends
- Annual dividend per share
- €0.70
- Dividend yield
- 3.1%
- Payout ratio
- 12.5%
- Ex-dividend date
- May 18, 2026
Analysts and estimates
- Average price target
- €28.33
- Median price target
- €30.00
- High price target
- €34.00
- Low price target
- €21.00
- Analysts with a price target
- 3
- Consensus
- Buy
- Forward EPS
- -€0.25
- EPS estimate, current year
- €0.65
Shares and trading
- Beta
- -0.02
- Average volume
- 22.72K
- Shares outstanding
- 28.87M
- Float
- 10.71M
- Institutional ownership
- 9.2%
- Insider ownership
- 62.2%